Skip to main content

Viral Heparin-Binding Complement Inhibitors – A Recurring Theme

  • Conference paper

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 598))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akula, S.M., Pramod, N.P., Wang, F.Z., and Chandran, B. (2001) Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284, 235-49.

    Article  PubMed  CAS  Google Scholar 

  • Albrecht, J.C., Nicholas, J., Biller, D., Cameron, K.R., Biesinger, B., Newman, C., Wittmann, S., Craxton, M.A., Coleman, H., and Fleckenstein, B. (1992) Primary structure of the herpesvirus saimiri genome. J Virol 66s, 5047-58.

    PubMed  CAS  Google Scholar 

  • Arnold, J.N., Dwek, R.A., Rudd, P.M., and Sim, R.B. (2006) Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett 106, 103-10.

    Article  PubMed  CAS  Google Scholar 

  • Avrameas, S. (1991) Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’. Immunol Today 12, 154-9.

    PubMed  CAS  Google Scholar 

  • Bajtay, Z., Speth, C., Erdei, A., and Dierich, M.P. (2004) Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18) J Immunol 173, 4775-8.

    PubMed  CAS  Google Scholar 

  • Banki, Z., Stoiber, H., and Dierich, M.P. (2005) HIV and human complement: inefficient virolysis and effective adherence. Immunol Lett 97, 209-14.

    Article  PubMed  CAS  Google Scholar 

  • Blackmore, T.K., Hellwage, J., Sadlon, T.A., Higgs, N., Zipfel, P.F., Ward, H.M., and Gordon, D.L. (1998) Identification of the second heparin-binding domain in human complement factor H. J Immunol 160, 3342-8.

    PubMed  CAS  Google Scholar 

  • Blom, A.M., Kask, L., and Dahlback, B. (2001) Structural requirements for the complement regulatory activities of C4BP. J Biol Chem 276, 27136-44.

    Article  PubMed  CAS  Google Scholar 

  • Caprioli, J., Bettinaglio, P., Zipfel, P.F., Amadei, B., Daina, E., Gamba, S., Skerka, C., Marziliano, N., Remuzzi, G., and Noris, M. (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 12, 297-307. Notes: CORPORATE NAME: Itaslian Registry of Familial and Recurrent HUS/TTP

    PubMed  CAS  Google Scholar 

  • Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., and Knowles, D.M. (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332, 1186-91.

    Article  PubMed  CAS  Google Scholar 

  • Chen, Y.T., Wang, Y.H., Cheng, Y.Y., and Hung, S.L. (2003) Direct binding of herpes simplex virus type 1 virions to complement C3. Viral Immunol 16, 347-55.

    Article  PubMed  CAS  Google Scholar 

  • Daniels, C.A., Borsos, T., Rapp, H.J., Snyderman, R., and Notkins, A.L. (1970) Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A 65, 528-35.

    Article  PubMed  CAS  Google Scholar 

  • Eizuru, Y., Ueno, I., and Minamishima, Y. (1988) Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement. J Clin Microbiol 26, 1881-3.

    PubMed  CAS  Google Scholar 

  • Endo, Y., Takahashi, M., and Fujita, T. (2006) Lectin complement system and pattern recognition. Immunobiology 211, 283-93.

    Article  PubMed  CAS  Google Scholar 

  • Fodor, W.L., Rollins, S.A., Bianco-Caron, S., Rother, R.P., Guilmette, E.R., Burton, W.V., Albrecht, J.C., Fleckenstein, B., and Squinto, S.P. (1995) The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J Virol 69, 3889-92.

    PubMed  CAS  Google Scholar 

  • Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Seidel, C.A., and Cines, D.B. (1984) Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309, 633-5.

    Article  PubMed  CAS  Google Scholar 

  • Friedman, H.M., Glorioso, J.C., Cohen, G.H., Hastings, J.C., Harris, S.L., and Eisenberg, R.J. (1986) Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates. J Virol 60, 470-5.

    PubMed  CAS  Google Scholar 

  • Friedman, H.M., Wang, L., Fishman, N.O., Lambris, J.D., Eisenberg, R.J., Cohen, G.H., and Lubinski, J. (1996) Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J Virol 70, 4253-60.

    PubMed  CAS  Google Scholar 

  • Fries, L.F., Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Hammer, C.H., and Frank, M.M. (1986) Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 137, 1636-41.

    PubMed  CAS  Google Scholar 

  • Galili, U., Mandrell, R.E., Hamadeh, R.M., Shohet, S.B., and Griffiss, J.M. (1988a) Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 56, 1730-7.

    CAS  Google Scholar 

  • Galili, U., Shohet, S.B., Kobrin, E., Stults, C.L., and Macher, B.A. (1988b) Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 263, 17755-62.

    CAS  Google Scholar 

  • Ganesh, V.K., Smith, S.A., Kotwal, G.J., and Murthy, K.H. (2004) Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation. Proc Natl Acad Sci U S A 101, 8924-9.

    Article  PubMed  CAS  Google Scholar 

  • Gerber, S.I., Belval, B.J., and Herold, B.C. (1995) Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214, 29-39.

    Article  PubMed  CAS  Google Scholar 

  • Ghebremariam, Y.T., Odunuga, O.O., Janse, K., and Kotwal, G.J. (2005) Humanized Recombinant Vaccinia Virus Complement Control Protein (hrVCP) with Three Amino Acid Changes, H98Y, E102K, and E120K Creating an Additional Putative Heparin Binding Site, Is 100-fold More Active Than rVCP in Blocking Both Classical and Alternative Complement Pathways. Ann N Y Acad Sci 1056, 113-22.

    Article  PubMed  CAS  Google Scholar 

  • Goodfellow, I.G., Evans, D.J., Blom, A.M., Kerrigan, D., Miners, J.S., Morgan, B.P., and Spiller, O.B. (2005) Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol 79, 12016-24.

    Article  PubMed  CAS  Google Scholar 

  • Green, T.D., Montefiori, D.C., and Ross, T.M. (2003) Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J Virol 77, 2046-55.

    Article  PubMed  CAS  Google Scholar 

  • Harris, C.L., Spiller, O.B., and Morgan, B.P. (2000) Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities. Immunology 100, 462-70.

    Article  PubMed  CAS  Google Scholar 

  • Harris, S.L., Frank, I., Yee, A., Cohen, G.H., Eisenberg, R.J., and Friedman, H.M. (1990) Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis 162, 331-7.

    PubMed  CAS  Google Scholar 

  • Herold, B.C., Visalli, R.J., Susmarski, N., Brandt, C.R., and Spear, P.G. (1994) Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol 75 ( Pt 6), 1211-22.

    PubMed  CAS  Google Scholar 

  • Herold, B.C., WuDunn, D., Soltys, N., and Spear, P.G. (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 65, 1090-8.

    PubMed  CAS  Google Scholar 

  • Herzenberg, L.A. and Kantor, A.B. (1993) B-cell lineages exist in the mouse. Immunol Today 14, 79-83; discussion 88-90.

    Article  PubMed  CAS  Google Scholar 

  • Hileman, R.E., Fromm, J.R., Weiler, J.M., and Linhardt, R.J. (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20, 156-67.

    Article  PubMed  CAS  Google Scholar 

  • Homa, F.L., Purifoy, D.J., Glorioso, J.C., and Levine, M. (1986) Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody. J Virol 58, 281-9.

    PubMed  CAS  Google Scholar 

  • Hook, L.M., Lubinski, J.M., Jiang, M., Pangburn, M.K., and Friedman, H.M. (2006) Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. J Virol 80, 4038-46.

    Article  PubMed  CAS  Google Scholar 

  • Huemer, H.P., Broker, M., Larcher, C., Lambris, J.D., and Dierich, M.P. (1989) The central segment of herpes simplex virus type 1 glycoprotein C (gC) is not involved in C3b binding: demonstration by using monoclonal antibodies and recombinant gC expressed in Escherichia coli. J Gen Virol 70 (Pt 6), 1571-8.

    PubMed  CAS  Google Scholar 

  • Huemer, H.P., Larcher, C., and Coe, N.E. (1992) Pseudorabies virus glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res 23, 271-80.

    Article  PubMed  CAS  Google Scholar 

  • Huemer, H.P., Nowotny, N., Crabb, B.S., Meyer, H., and Hubert, P.H. (1995) gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res 37, 113-26.

    Article  PubMed  CAS  Google Scholar 

  • Huemer, H.P., Wang, Y., Garred, P., Koistinen, V., and Oppermann, S. (1993) Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology 79, 639-47.

    PubMed  CAS  Google Scholar 

  • Huemer, H.P., Wechselberger, C., Bennett, A.M., Falke, D., and Harrington, L. (2003) Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): protection from complement-mediated cell lysis. J Gen Virol 84, 1091-100.

    Article  PubMed  CAS  Google Scholar 

  • Hung, S.L., Peng, C., Kostavasili, I., Friedman, H.M., Lambris, J.D., Eisenberg, R.J., and Cohen, G.H. (1994) The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 203, 299-312.

    Article  PubMed  CAS  Google Scholar 

  • Hung, S.L., Srinivasan, S., Friedman, H.M., Eisenberg, R.J., and Cohen, G.H. (1992) Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J Virol 66, 4013-27.

    PubMed  CAS  Google Scholar 

  • Isaacs, S.N., Kotwal, G.J., and Moss, B. (1992) Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A 89, 628-32.

    Article  PubMed  CAS  Google Scholar 

  • Kapadia, S.B., Levine, B., Speck, S.H., and Virgin, H.W. 4th (2002) Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 17, 143-55.

    Article  PubMed  CAS  Google Scholar 

  • Kapadia, S.B., Molina, H., van Berkel, V., Speck, S.H., and Virgin, H.W. 4th (1999) Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 73, 7658-70.

    PubMed  CAS  Google Scholar 

  • Kostavasili, I., Sahu, A., Friedman, H.M., Eisenberg, R.J., Cohen, G.H., and Lambris, J.D. (1997) Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J Immunol 158, 1763-71.

    PubMed  CAS  Google Scholar 

  • Kotwal, G.J., Isaacs, S.N., McKenzie, R., Frank, M.M., and Moss, B. (1990) Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250, 827-30.

    Article  PubMed  CAS  Google Scholar 

  • Kotwal, G.J. and Moss, B. (1988) Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335, 176-8.

    Article  PubMed  CAS  Google Scholar 

  • Lewis, R.B., Matzke, D.S., Albrecht, T.B., and Pollard, R.B. (1986) Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay. Rev Infect Dis 8 Suppl 4, S434-8.

    Google Scholar 

  • Linhardt, R.J. (2003) 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. J Med Chem 46, 2551-64.

    Article  PubMed  CAS  Google Scholar 

  • Liszewski, M.K., Leung, M.K., Hauhart, R., Buller, R.M., Bertram, P., Wang, X., Rosengard, A.M., Kotwal, G.J., and Atkinson, J.P. (2006) Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J Immunol 176, 3725-34.

    PubMed  CAS  Google Scholar 

  • Lubinski, J., Wang, L., Mastellos, D., Sahu, A., Lambris, J.D., and Friedman, H.M. (1999) In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med 190, 1637-46.

    Article  PubMed  CAS  Google Scholar 

  • Lubinski, J.M., Wang, L., Soulika, A.M., Burger, R., Wetsel, R.A., Colten, H., Cohen, G.H., Eisenberg, R.J., Lambris, J.D., and Friedman, H.M. (1998) Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J Virol 72, 8257-63.

    PubMed  CAS  Google Scholar 

  • Maeda, K., Hayashi, S., Tanioka, Y., Matsumoto, Y., and Otsuka, H. (2002) Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC) Virus Res 84, 79-87.

    Article  PubMed  CAS  Google Scholar 

  • Mardberg, K., Trybala, E., Glorioso, J.C., and Bergstrom, T. (2001) Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. J Gen Virol 82, 1941-50.

    PubMed  CAS  Google Scholar 

  • Mark, L., Lee, W.H., Spiller, O.B., Villoutreix, B.O., and Blom, A.M. (2006) The Kaposi’s sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2. Mol Immunol 43, 1665-75.

    Article  PubMed  CAS  Google Scholar 

  • McGrath, Y., Wilkinson, G.W., Spiller, O.B., and Morgan, B.P. (1999) Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseases. J Immunol 163, 6834-40.

    PubMed  CAS  Google Scholar 

  • McKenzie, R., Kotwal, G.J., Moss, B., Hammer, C.H., and Frank, M.M. (1992) Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis 166, 1245-50.

    PubMed  CAS  Google Scholar 

  • McNearney, T.A., Odell, C., Holers, V.M., Spear, P.G., and Atkinson, J.P. (1987) Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med 166, 1525-35.

    Article  PubMed  CAS  Google Scholar 

  • Morgan, B.P., Marchbank, K.J., Longhi, M.P., Harris, C.L., and Gallimore, A.M. (2005) Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett 97, 171-9.

    Article  PubMed  CAS  Google Scholar 

  • Mullick, J., Bernet, J., Singh, A.K., Lambris, J.D., and Sahu, A. (2003). Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J Virol 77, 3878-81.

    Article  PubMed  CAS  Google Scholar 

  • Mullick, J., Singh, A.K., Panse, Y., Yadav, V., Bernet, J., and Sahu, A. (2005). Identification of functional domains in kaposica, the complement control protein homolog of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 79, 5850-6.

    Article  PubMed  CAS  Google Scholar 

  • Murthy, K.H., Smith, S.A., Ganesh, V.K., Judge, K.W., Mullin, N., Barlow, P.N., Ogata, C.M., and Kotwal, G.J. (2001) Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104, 301-11.

    Article  PubMed  CAS  Google Scholar 

  • Olofsson, S., Bolmstedt, A., Biller, M., Mardberg, K., Leckner, J., Malmstrom, B.G., Trybala, E., and Bergstrom, T. (1999) The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC. Glycobiology 9, 73-81.

    Article  PubMed  CAS  Google Scholar 

  • Oppermann, M., Manuelian, T., Jozsi, M., Brandt, E., Jokiranta, T.S., Heinen, S., Meri, S., Skerka, C., Gotze, O., and Zipfel, P.F. (2006) The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin Exp Immunol 144, 342-52.

    Article  PubMed  CAS  Google Scholar 

  • Perez-Caballero, D., Gonzalez-Rubio, C., Gallardo, M.E., Vera, M., Lopez-Trascasa, M., Rodriguez de Cordoba, S., and Sanchez-Corral, P. (2001) Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 68, 478-84.

    Article  PubMed  CAS  Google Scholar 

  • Petitou, M., Casu, B., and Lindahl, U. (2003) 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie 85, 83-9.

    Article  PubMed  CAS  Google Scholar 

  • Pinter, C., Beltrami, S., Stoiber, H., Negri, D.R., Titti, F., and Clivio, A. (2000) Interference with complement regulatory molecules as a possible therapeutic strategy in HIV infection. Expert Opin Investig Drugs 9, 199-205.

    Article  PubMed  CAS  Google Scholar 

  • Richards, A., Buddles, M.R., Donne, R.L., Kaplan, B.S., Kirk, E., Venning, M.C., Tielemans, C.L., Goodship, J.A., and Goodship, T.H. (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet 68, 485-90.

    Article  PubMed  CAS  Google Scholar 

  • Rioux, P. (2001) TP-10 (AVANT Immunotherapeutics) Curr Opin Investig Drugs 2, 364-71.

    PubMed  CAS  Google Scholar 

  • Rooijakkers, S.H. and van Strijp, J.A. (2007) Bacterial complement evasion. Mol Immunol 44, 23-32.

    Article  PubMed  CAS  Google Scholar 

  • Rosengard, A.M., Liu, Y., Nie, Z., and Jimenez, R. (2002) Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci U S A 99, 8808-13.

    PubMed  CAS  Google Scholar 

  • Rundell, B.B. and Betts, R.F. (1982) Neutralization and sensitization of cytomegalovirus by IgG antibody, anti-IgG antibody, and complement. J Med Virol 10, 109-18.

    Article  PubMed  CAS  Google Scholar 

  • Russo, J.J., Bohenzky, R.A., Chien, M.C., Chen, J., Yan, M., Maddalena, D., Parry, J.P., Peruzzi, D., Edelman, I.S., Chang, Y., and Moore, P.S. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) Proc Natl Acad Sci U S A 93, 14862-7.

    Article  PubMed  CAS  Google Scholar 

  • Saevarsdottir, S., Vikingsdottir, T., and Valdimarsson, H. (2004) The potential role of mannan-binding lectin in the clearance of self-components including immune complexes. Scand J Immunol 60, 23-9.

    Article  PubMed  CAS  Google Scholar 

  • Sahu, A., Isaacs, S.N., Soulika, A.M., and Lambris, J.D. (1998) Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J Immunol 160, 5596-604.

    PubMed  CAS  Google Scholar 

  • Seidel-Dugan, C., Ponce de Leon, M., Friedman, H.M., Eisenberg, R.J., and Cohen, G.H. (1990) Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol 64, 1897-906.

    PubMed  CAS  Google Scholar 

  • Seidel-Dugan, C., Ponce de Leon, M., Friedman, H.M., Fries, L.F., Frank, M.M., Cohen, G.H., and Eisenberg, R.J. (1988) C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. J Virol 62, 4027-36.

    PubMed  CAS  Google Scholar 

  • Sharma, A.K. and Pangburn, M.K. (1996) Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl Acad Sci U S A 93, 10996-1001.

    Article  PubMed  CAS  Google Scholar 

  • Singh, A.K., Mullick, J., Bernet, J., and Sahu, A. (2006) Functional characterization of the complement control protein homolog of herpesvirus saimiri: ARG-118 is critical for factor I cofactor activities. J Biol Chem 281, 23119-28.

    Article  PubMed  CAS  Google Scholar 

  • Smith, S.A., Mullin, N.P., Parkinson, J., Shchelkunov, S.N., Totmenin, A.V., Loparev, V.N., Srisatjaluk, R., Reynolds, D.N., Keeling, K.L., Justus, D.E., Barlow, P.N., and Kotwal, G.J. (2000) Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J Virol 74s, 5659-66.

    Article  PubMed  CAS  Google Scholar 

  • Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d’Agay, M.F., Clauvel, J.P., Raphael, M., and Degos, L. (1995). Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86, 1276-80.

    PubMed  CAS  Google Scholar 

  • Spear, G.T., Lurain, N.S., Parker, C.J., Ghassemi, M., Payne, G.H., and Saifuddin, M. (1995) Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV) J Immunol 155, 4376-81.

    PubMed  CAS  Google Scholar 

  • Spiller, O.B., Blackbourn, D.J., Mark, L., Proctor, D.G., and Blom, A.M. (2003) Functional activity of the complement regulator encoded by Kaposi’s sarcoma-associated herpesvirus. J Biol Chem 278, 9283-9.

    Article  PubMed  CAS  Google Scholar 

  • Spiller, O.B., Hanna, S.M., Devine, D.V., and Tufaro, F. (1997) Neutralization of cytomegalovirus virions: the role of complement. J Infect Dis 176, 339-47.

    Article  PubMed  CAS  Google Scholar 

  • Spiller, O.B., Mark, L., Blue, C.E., Proctor, D.G., Aitken, J.A., Blom, A.M., and Blackbourn, D.J. (2006) Dissecting the regions of virion-associated Kaposi’s sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J Virol 80, 4068-78.

    Article  PubMed  CAS  Google Scholar 

  • Spiller, O.B. and Morgan, B.P. (1998) Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts. J Infect Dis 178, 1597-603.

    Article  PubMed  CAS  Google Scholar 

  • Spiller, O.B., Morgan, B.P., Tufaro, F., and Devine, D.V. (1996) Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur J Immunol 26, 1532-8.

    Article  PubMed  CAS  Google Scholar 

  • Spiller, O.B., Robinson, M., O’Donnell, E., Milligan, S., Morgan, B.P., Davison, A.J., and Blackbourn, D.J. (2003) Complement regulation by Kaposi’s sarcoma-associated herpesvirus ORF4 protein. J Virol 77, 592-9.

    Article  PubMed  CAS  Google Scholar 

  • Tal-Singer, R., Peng, C., Ponce De Leon, M., Abrams, W.R., Banfield, B.W., Tufaro, F., Cohen, G.H., and Eisenberg, R.J. (1995) Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol 69, 4471-83.

    PubMed  CAS  Google Scholar 

  • Tal-Singer, R., Seidel-Dugan, C., Fries, L., Huemer, H.P., Eisenberg, R.J., Cohen, G.H., and Friedman, H.M. (1991) Herpes simplex virus glycoprotein C is a receptor for complement component iC3b. J Infect Dis 164, 750-3.

    PubMed  CAS  Google Scholar 

  • Thieblemont, N., Haeffner-Cavaillon, N., Ledur, A., L’Age-Stehr, J., Ziegler-Heitbrock, H.W., and Kazatchkine, M.D. (1993) CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4. Clin Exp Immunol 92, 106-13.

    Article  PubMed  CAS  Google Scholar 

  • Trybala, E., Bergstrom, T., Svennerholm, B., Jeansson, S., Glorioso, J.C., and Olofsson, S. (1994) Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. J Gen Virol 75 ( Pt 4), 743-52.

    Article  PubMed  CAS  Google Scholar 

  • Vanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R.B., and Smith, G.L. (1998) Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A 95, 7544-9.

    Article  PubMed  CAS  Google Scholar 

  • Walport, M.J. (2001) Complement. First of two parts. N Engl J Med 344, 1058-66.

    Article  PubMed  CAS  Google Scholar 

  • Wang, F.Z., Akula, S.M., Pramod, N.P., Zeng, L., and Chandran, B. (2001) Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75, 7517-27.

    Article  PubMed  CAS  Google Scholar 

  • Watanabe, I., Ross, T.M., Tamura, S., Ichinohe, T., Ito, S., Takahashi, H., Sawa, H., Chiba, J., Kurata, T., Sata, T., and Hasegawa, H. (2003) Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine 21, 4532-8.

    Article  PubMed  CAS  Google Scholar 

  • Wu, C.T., Levine, M., Homa, F., Highlander, S.L., and Glorioso, J.C. (1990) Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants. J Virol 64, 856-63.

    PubMed  CAS  Google Scholar 

  • Yu, H., Munoz, E.M., Edens, R.E., and Linhardt, R.J. (2005) Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta 1726, 168-76.

    PubMed  CAS  Google Scholar 

  • Zipfel, P.F. (2001) Complement factor H: physiology and pathophysiology. Semin Thromb Hemost 27, 191-9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this paper

Cite this paper

Blom, A.M., Mark, L., Spiller, O.B. (2007). Viral Heparin-Binding Complement Inhibitors – A Recurring Theme. In: Lambris, J.D. (eds) Current Topics in Innate Immunity. Advances in Experimental Medicine and Biology, vol 598. Springer, New York, NY. https://doi.org/10.1007/978-0-387-71767-8_9

Download citation

Publish with us

Policies and ethics